Tag: clinical-stage biotechnology
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing...